A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome
Resource Type
Article
Authors
Koziolek, Michael ; Bramlage, Carsten Paul ; Weber, Frauke ; Albrecht-Nock, Tanja ; Sonntag, Joseph ; Frese, Jenny ; Kettwig, Matthias ; Hilgers, Reinhard ; Hansen, Matthias ; Wedekin, Mirja ; Meyer, Nicole ; Klaiber, Susanne ; Gessner, Michaela ; Liebau, Max ; Vogt-Weigeldt, Anne-Kristin ; Jungraithmayr, Therese ; Ponsel, Sabine ; Jacoby, Ulrike ; Konrad, Martin ; Kranz, Brigitta ; Koenig, Jens ; Loechtermann, Lisa ; Pohl, Michael ; Husain, Ralf ; Mueller, Katrin ; Thumfart, Julia ; Schalk, Gesa ; Feldkoetter, Markus ; Schmidt, Sabine ; Sauerstein, Katja ; Muschiol, Evelin ; Billing, Heiko ; Wilkening, Frauke ; Gross, Oliver ; Tönshoff, Burkhard ; Weber, Lutz T. ; Pape, Lars ; Latta, Kay ; Fehrenbach, Henry ; Lange-Sperandio, Baerbel ; Zappel, Hildegard ; Hoyer, Peter ; Staude, Hagen ; König, Sabine ; John, Ulrike ; Gellermann, Jutta ; Hoppe, Bernd ; Galiano, Matthias ; Hoecker, Britta ; Ehren, Rasmus ; Lerch, Christian ; Kashtan, Clifford E. ; Harden, Markus ; Boeckhaus, Jan ; Friede, Tim
Source
In Kidney International June 2020 97(6):1275-1286
Subject
Language
ISSN
0085-2538